Ide-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses.

Autor: Ailawadhi S; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL., Arnulf B; Immuno-Hématologie, Hôpital Saint-Louis, l'Assistance publique-Hôpitaux de Paris, Université Paris Cite, Paris, France., Patel K; Department of Lymphoma-Myeloma, MD Anderson Cancer Center, The University of Texas, Houston, TX., Cavo M; Department of Medical and Surgical Sciences, Istituto di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy., Nooka AK; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA., Manier S; Medical and Oncology Specialties Department, Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France., Callander N; Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, WI., Costa LJ; Hematology & Oncology, The University of Alabama at Birmingham, Birmingham, AL., Vij R; Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO., Bahlis NJ; Department of Oncology, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Moreau P; Hematology Department, University Hospital of Nantes, Nantes, France., Solomon S; Transplant and Cellular Immunotherapy Program, Northside Hospital Cancer Institute, Atlanta, GA., Abrahamsen IW; Department of Immunology, Oslo University Hospital, Oslo, Norway., Baz R; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Broijl A; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Chen C; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Jagannath S; Multiple Myeloma Center of Excellence at Tisch Cancer Institute, Mount Sinai Medical Center, New York, NY., Raje N; Center for Multiple Myeloma, Massachusetts General Hospital, Boston, MA., Scheid C; Department of Medicine, University of Cologne, Cologne, Germany., Delforge M; Department of Hematology, Universitaire Ziekenhuizen Leuven, Leuven, Belgium., Benjamin R; Department of Heamatology, Kings College Hospital, London, United Kingdom., Pabst T; Department of Medical Oncology, Bern University Hospital, Bern, Switzerland., Iida S; Department of Hematology & Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Berdeja J; Sarah Cannon Cancer Center and Tennessee Oncology, Nashville, TN., Giralt S; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Truppel-Hartmann A; 2seventy bio, Cambridge, MA., Chen Y; Bristol Myers Squibb, Princeton, NJ., Zhong X; Bristol Myers Squibb, Princeton, NJ., Wu F; Bristol Myers Squibb, Princeton, NJ., Piasecki J; Bristol Myers Squibb, Princeton, NJ., Eliason L; Bristol Myers Squibb, Princeton, NJ., Dhanda D; Bristol Myers Squibb, Princeton, NJ., Felten J; Bristol Myers Squibb, Boudry, Switzerland., Caia A; Bristol Myers Squibb, Boudry, Switzerland., Cook M; Bristol Myers Squibb, Boudry, Switzerland., Popa McKiver M; Bristol Myers Squibb, Princeton, NJ., Rodríguez-Otero P; Department of Hematology, Clínica Universidad de Navarra, Pamplona, Spain.

Publikováno v: Blood [Blood] 2024 Dec 05; Vol. 144 (23), pp. 2389-2401.

Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy.

Autor: Itzhaki Ben Zadok O; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (O.I.B.Z., P.S., A.N.).; Faculty of Medicine, Tel-Aviv University, Israel (O.I.B.Z.)., Simitsis P; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (O.I.B.Z., P.S., A.N.)., Jacobson C; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA (C.J., O.N., C.D., P.C., J.D.C., A.L., A.N.)., Nadeem O; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA (C.J., O.N., C.D., P.C., J.D.C., A.L., A.N.)., Frigault MJ; Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Boston (M.J.F., N.R.)., Raje N; Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Boston (M.J.F., N.R.)., Duffy C; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA (C.J., O.N., C.D., P.C., J.D.C., A.L., A.N.)., Costello P; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA (C.J., O.N., C.D., P.C., J.D.C., A.L., A.N.)., Dela Cruz J; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA (C.J., O.N., C.D., P.C., J.D.C., A.L., A.N.)., Looka A; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA (C.J., O.N., C.D., P.C., J.D.C., A.L., A.N.)., Nohria A; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (O.I.B.Z., P.S., A.N.).; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA (C.J., O.N., C.D., P.C., J.D.C., A.L., A.N.).

Publikováno v: Circulation [Circulation] 2024 Nov 26; Vol. 150 (22), pp. 1815-1817. Date of Electronic Publication: 2024 Nov 25.

Multiple myeloma: What is the most cost-effective imaging strategy for initial detection of bone lesions?

Autor: Gyftopoulos S; Department of Radiology, NYU Langone Health, New York, NY, USA.; Department of Orthopedic Surgery, NYU Langone Health, New York, NY, USA., Hanly A; Division of Musculoskeletal Imaging and Intervention, Department of Radiology, Massachusetts General Hospital, Yawkey 6E55 Fruit Street, Boston, MA, 02114, USA., Subhas N; Department of Radiology, Cleveland Clinic, Cleveland, OH, USA., Raje N; Department of Medicine Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Chang CY; Division of Musculoskeletal Imaging and Intervention, Department of Radiology, Massachusetts General Hospital, Yawkey 6E55 Fruit Street, Boston, MA, 02114, USA. cychang@mgh.harvard.edu.

Publikováno v: Skeletal radiology [Skeletal Radiol] 2024 Oct 28. Date of Electronic Publication: 2024 Oct 28.

Investigation of cord-rubber composite durability by the material force method

Autor: Popa, C.M., Gebhardt, C., Raje, N., Steenwyk, B., Kaliske, M.

Publikováno v: In Engineering Fracture Mechanics 15 April 2020 229

Hearing Loss in Children with 22q11.2 Deletion Syndrome.

Autor: Arganbright J; Division of Pediatric Otolaryngology, Children's Mercy Hospital, Kansas, Missouri, U.S.A.; University of Missouri-Kansas City School of Medicine, Kansas, Missouri, U.S.A., Crowley TB; 22q and You Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A.; Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A., Tracy M; Division of Pediatric Otolaryngology, Children's Mercy Hospital, Kansas, Missouri, U.S.A., Noel-MacDonnell J; University of Missouri-Kansas City School of Medicine, Kansas, Missouri, U.S.A.; Health Services and Outcomes Research, Children's Mercy Hospital, Kansas, Missouri, U.S.A., Gaiser K; 22q and You Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A.; Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A., Yaktine L; Division of Hearing and Speech, Children's Mercy Hospital, Kansas, Missouri, U.S.A., Moore A; Division of Hearing and Speech, Children's Mercy Hospital, Kansas, Missouri, U.S.A., Hamm J; Division of Hearing and Speech, Children's Mercy Hospital, Kansas, Missouri, U.S.A., Morrow B; Albert Einstein Collect of Medicine, Bronx, New York, U.S.A., Song H; Albert Einstein Collect of Medicine, Bronx, New York, U.S.A., Giunta V; 22q and You Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A.; Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A., McGinn DE; 22q and You Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A.; Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A., Zackai EH; 22q and You Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A.; Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A.; Department of Pediatrics, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A., Emanuel B; 22q and You Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A.; Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A.; Department of Pediatrics, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A., Elden L; 22q and You Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A.; Department of Surgery, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A.; Division of Otolaryngology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A., Narayanan S; University of Missouri-Kansas City School of Medicine, Kansas, Missouri, U.S.A., Raje N; Division of Pediatric Allergy, Asthma, & Immunology, Children's Mercy Hospital, Kansas, Missouri, U.S.A., McDonald-McGinn DM; 22q and You Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A.; Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A.; Department of Pediatrics, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A.; Division of Human Biology and Medical Genetics, Sapienza, University, Rome, Italy.

Publikováno v: The Laryngoscope [Laryngoscope] 2024 Sep 21. Date of Electronic Publication: 2024 Sep 21.